Connection

Fengcai Zhu to Enterovirus Infections

This is a "connection" page, showing publications Fengcai Zhu has written about Enterovirus Infections.
Connection Strength

2.231
  1. Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation. Hum Vaccin Immunother. 2018 06 03; 14(6):1517-1523.
    View in: PubMed
    Score: 0.506
  2. A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3-5 years and infants aged 6-35 months. Expert Rev Vaccines. 2018 03; 17(3):257-262.
    View in: PubMed
    Score: 0.499
  3. 2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study. J Infect Dis. 2017 Jan 01; 215(1):56-63.
    View in: PubMed
    Score: 0.456
  4. [Epidemiological characteristics of enterovirus type 71 diseases]. Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Jan; 36(1):45-8.
    View in: PubMed
    Score: 0.403
  5. Seroepidemiology of enterovirus D68 infection in infants and children in Jiangsu, China. J Infect. 2018 06; 76(6):563-569.
    View in: PubMed
    Score: 0.125
  6. Seroepidemiology of coxsackievirus B5 in infants and children in Jiangsu province, China. Hum Vaccin Immunother. 2018 01 02; 14(1):74-80.
    View in: PubMed
    Score: 0.123
  7. Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints. Expert Rev Vaccines. 2017 09; 16(9):945-949.
    View in: PubMed
    Score: 0.119
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.